Gujarat Pharma Industry Faces Limited US Disruption

Despite recent regulatory actions by the US government, the pharmaceutical industry in Gujarat, India, is reporting only limited disruption to its operations. Industry leaders are emphasizing the need for a proactive approach to address these challenges. They are calling for increased investment in research and development to ensure the industry remains competitive on a global scale. Additionally, there is a strong push for a more robust regulatory framework that can effectively navigate the complexities of international pharmaceutical markets.